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INTRODUCTION
Upper gastrointestinal bleeding (UGIB) is a potentially
fatal, time-critical presenting complaint in the
emergency department (ED).1,2 The burden it presents
can be compounded in resource poor settings, where
patients often pay out-of-pocket for care, thereby
hampering appropriate early intervention to determine
the location and severity of  bleeding. The incidence is
approximately 1% of  all ED admissions. 3 The
increasing use of low dose aspirin and non-steroidal
anti-inflammatory drugs (NSAIDs) may affect the
incidence, age of presentation, site of bleeding and
outcome of  UGIB. NSAIDs cause gastrointestinal
mucosa damage, ulceration and ulcer complication by
the inhibition of endogenous prostaglandin synthesis
via cyclo-oxygenase-1 enzyme.4,5 Despite improvement
in diagnosis and management such as the introduction
of  therapeutic endoscopies and interventional
radiology, mortality remains high 5-10%.6,7 There is a
dearth of health data depicting the clinical characteristics
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of  the condition in African countries. To the best of
our knowledge, few studies have looked into ED
presentations of UGIB in Nigeria hence we set out to
describe the demographic, clinical characteristics and
outcome of  these cases.
METHODS
After obtaining institutional ethical approval, we
retrospectively reviewed records of cohort of patients
who presented to the ED of the University College
Hospital, Ibadan, with UGIB between 1 January 2011
and 31 December 2012 from point of admission to
discharge or death. This study was carried out at a
university teaching hospital emergency department,
which receives over 10,000 unrestricted emergencies
annually with an admission rate of 47%. All medical,
surgical, obstetric, gynaecological emergencies above
12 years as well as paediatric trauma cases were
attended to at our centre, which serves as a referral
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association between mortality and diastolic blood pressure; more deaths (1/7;
14.3%) occurred in those with diastolic blood pressure > 90mmHg compared
with <90mmHg (5/70; 7.1%) (P = 0.002). There were more deaths among patients
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centre to other hospitals in the locality. UGIB refers
to vomiting blood (haematemesis) or coffee-ground
substance (melaenemesis) and/or black tarry stools
(melaena). At presentation, initial evaluation was
conducted to assess severity of bleeding, co-
morbidities and risk factors. The patient’s cardiovascular
vital signs were recorded to assess haemodynamic
stability and necessary resuscitation commenced. The
data obtained from the departmental e-register
included age, presenting symptoms, history of acid
peptic disease, NSAID use, alcohol ingestion, time and
duration of ED admission, discharge and admission
to wards for further review or death. Information
such as history of  previous UGIB, co-morbidities,
diagnostic endoscopy, duration of  bleeding before
presentation, haematocrit value at presentation, packed
cell volume measurements are recorded in patient’s
case notes.
Data were analysed using Statistical Package for Social
Sciences (SPSS version 17.0; Chicago, IL, USA). Simple
descriptive statistics were used. Mean and standard
deviation was generated for continuous variables, while
chi-square test was used to explore the relationship
between mortality and the demographic/clinical
characteristics. P values <0.05 were considered
statistically significant.
RESULTS
A total of 20, 939 patients of which 8281 were medical
cases were seen over the study period. Among the
medical cases, there were 169 patients with UGIB;
this constituted 0.8 % of the total admission and 2.0%
of  the medical cases. Only 77 patients’ files out of  the
169 was found, so data on many variables were
unavailable. The median age of patients with UGIB
was 44 years (range 13 – 89) and 27.2% were >60
years. Most (69.2%) of  the patients were male; with a
male to female ratio of  2.3:1 (Table 1). The most
common presenting symptom was haematemesis
(34.9%) followed by melaena (16.6%). A high
proportion (42%) presented at the ED during the
afternoon shift, another 1/3 occurred during the 12-
hour night shift. There was a positive history of
NSAIDs ingestion within 24-48 h in 16.8% and alcohol
ingestion in 12.0% (Table 2). The median hospitalisation
period was 20 hours (range 1 – 93 hours). Upper
gastrointestinal endoscopy (UGIE) was done only in
6.8% cases.
Twenty-three (13.6%) patients died; 44% within 5 hours
of admission and a high proportion (47.8%) occurred
during the night shift. Thirty-seven (21.9%) patients
had blood transfusion, 15% had >2 units of whole
blood. There was association between mortality and
diastolic blood pressure (Table 3); more deaths (1/7;
14.3%) occurred in those with diastolic blood pressure
>90mmHg compared to <90mmHg (5/70; 7.1%)
(P = 0.002). There was significant association between
mortality and blood transfusion; there were more
deaths among patients who did not receive blood
transfusion (4/40; 10.0%) compared with those who
had blood transfusion (2/37; 5.4%) (P= 0.008).
Table 1: Demographic characteristics of  patients with
UGIB n=169







































































Table 2: Clinical characteristics and outcome of  patients
with UGIB n=169












































































































Upper gastrointestinal bleeding is traditionally defined
as bleeding from the gastrointestinal tract that is
proximal to the ligament of  Treitz. It presents as
haematemesis, melaena or less predictively as
melaenemesis (coffee ground vomiting), and has had
a stable mortality of 10% worldwide, in spite of several
novel approaches to its treatment including the use of
endoclot powder spray, tranexamic acid, interventional
endoscopic procedures, among others.8,9 Of  the major
causes such as oesophagitis, varices, PUD, erosive
gastritis, variceal bleeding is known to carry a higher
fatality than peptic ulcer disease. Over the twenty four
month study period, we recorded one hundred and
sixty nine cases of  UGIB, suggesting an average annual
presentation of  84.5 cases. These (169 patients)
represent less than 1% of total emergency admission
and about 2% of medical cases seen over the period.
In a population-based study in the USA, it was
estimated that 100 per 100,000 adults are hospitalised
yearly, with incidence among men double that of
women, and increasing incidence with age.10,11 It is
evident that male predominance, in a ratio of 2.3:1 is
in consonance with previous studies.3,7,10 However,
about a quarter of our patients were above the age of
60 years, while the younger age groups constitute the
majority, with the age group 30 - 39 alone accounting
for 26%. The social and economic implications of
this are grave, as they constitute the workforce in any
viable economy. Atoba and Olubuyide in 1993
attributed the aetiology of  acute UGIB at our centre
to acute alcohol imbibition followed by NSAIDs12
while in Ilorin, Nigeria, abuse of NSAIDs was the
major implicated aetiological agent,13 though the
sample sizes were relatively smaller than ours. Our
Table 3: Relationship between UGIB patients’ characteristics and mortality
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finding showed that use of NSAIDs (16.8%) was the
commonest risk factor followed by alcohol. This
would suggest the need for more advocacy against
the reckless use of NSAIDs, though the use of
NSAIDs increase with aging due to some
arthrodegenerative changes, cardiovascular,
haematologic and oncologic use associated with
normal aging process, and susceptibility of  the aging
gastric mucosa to injury, the so-called “aging
gastropathy”. The use of NSAIDs is a well-established
risk factor for UGIB due to cyclo-oxygenase enzyme
inhibition of endogenous prostaglandin synthesis
making GI mucosa vulnerable to damage and
ulceration, any amount can cause bleeding but risk
increases with increasing dose. 5,14,15
About half of our studied patients presented with
haematemesis and coffee-ground vomiting (CGV) and
less than one-fifth presented with melaena. Unlike the
study reported by Olokoba et al13 in Ilorin, Nigeria,
haematemesis was the commonest presenting
symptom in our cohort of  patients. Co-morbid
medical conditions such as malignancy, organ failure,
respiratory disease, ischaemic heart disease and other
major systemic diseases were known to increase
mortality in a British study.11 The major co-morbidities
in our study were chronic liver disease (CLD),
hypertension, malignancies and diabetes mellitus (DM).
The exact contributions of these co-morbidities in our
patients could not be ascertained, our study being a
retrospective study.
The ED mortality of 13.6% recorded in our study is
high and greater than the predicted average of 10%,
but slightly lower than the overall mortality of 14% in
the British study earlier referred to11 which was
published in 1995 and recorded a mortality of 0.6%
among cases without co-morbidities. The contributory
factors could be co-morbidities and the lack of
endoscopic therapy as UGIE was carried out in only
6.8%. Endoscopic therapy is now a well-established
and effective treatment modality for UGIB.16 Higher
diastolic pressures (>90mmHg) which would suggest
an underlying hypertension (a co-morbid condition)
was another factor associated with higher mortality. A
previous multicenter study by de Groot and his
colleagues showed that UGIB patients admitted
during the weekend were at higher risk of an adverse
outcome compared to those admitted during
weekdays.17 While we did not consider weekday versus
weekend admissions, our study showed that most of
the patients were admitted during the afternoon shift.
The patients were at higher risk of mortality during
the night shift than the daytime, and blood transfusion
was associated with a positive outcome. The higher
mortality recorded during the night shifts may not be
unconnected with the practice of fewer staff of all
cadres on duty during night shifts in our hospitals and
the tendency for reduced alertness of staff during this
period. As this could occur in other service areas of
the hospital, it would be auspicious to study other areas
of  service such as medical records, surgeries and other
procedures comparing day and night shifts outcome,
though a Danish study did not find a significant
difference in observed errors during day and evening
shifts.18
Typical of  retrospective studies, there was failure to
document information such as duration of  bleeding
before presentation, haematocrit values, indices for
blood transfusion, timing and results of diagnostic
UGIE resulting in incomplete data in many patients.
The case notes of many patients who presented with
UGIB from the e-register could not be found. With
only 45.6% of  case notes retrieved in this study, we
were unable to explore the impact of more variables
on the outcome. We wish to recommend that efforts
should not be spared in improving documentation and
keeping patients’ records.
In conclusion, the mortality rate in our ED patients is
higher than the predicted average, and factors
associated with increased mortality were co-
morbidities, higher diastolic blood pressures and night
shift duties, while blood transfusion reduced mortality.
In view of the fact that our study was retrospective, it
could not be ascertained which category of medical
staff, whether specialist (gastroenterologist) or non-
specialist managed the cases and the possible
differences in outcomes. It is suggested that effective
blood transfusion and endoscopic services be put in
place in the ED in order to reduce mortalities
associated with UGIB. Societal education against
inordinate use of NSAIDs and alcohol needs to be
stepped up.
Department(s) and institution(s) to which the
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